서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 9 of 9

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2006-06	Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer Lee, Kyung-Hun; Han, Sae-Won; Hwang, Pil Gyu; Oh, Do-Youn; Kim, Dong-Wan; Chung, Doo Hyun; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.36 No.6, pp.344-350	DOI
2008-03	High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer Kim, D-W; Min, H. S.; Lee, K-H; Kim, Y. J.; Oh, D-Y; Jeon, Y. K.; Lee, S. -H.; Im, S. -A.; Chung, D. H.; Kim, Y. T.; Kim, T. -Y.; Bang, Y. -J.; Sung, S. W.; Kim, J. H.; Heo, D. S. British Journal of Cancer, Vol.98 No.6, pp.1118-1124	DOI
2008-06	ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer Lee, Kyung-Hun; Min, Hye Sook; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Kim, Young Tae; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Sung, Sook Whan; Kim, Joo Hyun Lung Cancer, Vol.60 No.3, pp.401-407	DOI
2008-07	Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment Han, Sae-Won; Kim, Hwang-Phill; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Lung Cancer, Vol.61 No.1, pp.30-34	DOI
2009-07	Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI Yi, Hyeon Gyu; Kim, Hye Jin; Kim, Yu Jung; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Kim, Chul Soo; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.65 No.1, pp.80-84	DOI
2009-09	Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Hur, Hyung-Seok; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.8 No.9, pp.2526-2536	DOI
2010-04	KRAS Mutant Lung Cancer Cells Are Differentially Responsive to MEK Inhibitor Due to AKT or STAT3 Activation: Implication for Combinatorial Approach Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Carcinogenesis, Vol.49 No.4, pp.353-362	DOI
2011-02	Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes Ku, Ja-Lok; Kim, Kyung-Hee; Choi, Jin-Sung; Jeon, You-Kyung; Kim, Sung-Hee; Shin, Young-Kyoung; Kim, Tae-You; Bang, Yung-Jue; Kim, Woo Ho; Park, Jae-Gahb Cellular Oncology, Vol.34 No.1, pp.45-54	DOI
2011-03	Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer Nam, Hyun-Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Hur, Hyung-Seok; Song, Sang-Hyun; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Letters, Vol.302 No.2, pp.155-165	DOI

1